As we continue further into the multidrug resistant era, it becomes necessary to develop a deeper understanding of how to perform and interpret antimicrobial susceptibility testing. The clinical microbiology laboratory provides valuable susceptibility data that can...
PathCare introduces Xpert MTB/XDR testing as a reflex test for rapid molecular drug susceptibility testing of rifampicin-resistant Mycobacterium tuberculosis (RR-TB) positive clinical samples South Africa remains one of the top 30 high-burden countries for...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during July 2025 (epidemiological weeks 27-31). The data is dependent on submission of samples by clinicians and therefore may not be...
We are pleased to announce an important enhancement to our endocrine diagnostics service. As of 29 July 2025, our laboratory will transition from reporting urine total (deconjugated) metanephrines (currently performed via HPLC) to urine free (unconjugated)...
